Texas 2011 - 82nd Regular

Texas Senate Bill SB1115

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to fraud against the state and actions by the state and private persons to prosecute those frauds; providing a civil penalty.

Impact

The amendments introduced by SB1115 may lead to a heightened awareness of fraud against the state and increased accountability among public servants and contractors. With the introduction of strict penalties for presenting false claims or statements regarding state funds, the law is designed to deter fraudulent activities and incentivize individuals to report misconduct. The qui tam provision is especially notable, as it not only empowers individuals to expose fraud but also entitles them to a share of any recovery, fostering an environment where whistleblowers are acknowledged and protected from retaliation. This might encourage more instances of reported fraud that previously went unaddressed.

Summary

SB1115 introduces significant amendments to the Texas Government Code, establishing a new chapter addressing fraud against the state. It empowers private individuals to act as whistleblowers through qui tam actions, allowing them to pursue unlawful acts against state funds, while also outlining the responsibilities of the Attorney General in investigating and prosecuting such cases. The bill's core intent is to strengthen legal mechanisms against defrauding state resources, which supporters argue is essential for maintaining the integrity of state funding and operations. It lays out the definitions of unlawful acts and the processes by which the state can engage in civil actions against offenders.

Sentiment

The sentiment surrounding SB1115 is generally positive among lawmakers advocating for increased transparency and accountability in state finance. Supporters perceive the law as a formidable tool in combating fraud, potentially saving taxpayer money and ensuring the fair use of state funds. However, critics express concerns about the potential for abuse of the qui tam system, whereby individuals may file frivolous claims for personal gain. The discourse reflects a balancing act between enhancing protections for whistleblowers and safeguarding against misuse of these provisions.

Contention

One area of contention is the bill's exclusion of Medicaid fraud cases, which some stakeholders argue could leave a significant gap in enforcement against health care-related fraud. Additionally, opponents worry that qui tam actions might lead to an increase in unsubstantiated claims that could burden the judicial system. The balance between protecting the state’s interests and maintaining fair legal processes is at the forefront of the discussions surrounding SB1115.

Companion Bills

No companion bills found.

Similar Bills

TX SB496

Relating to certain unlawful acts involving state money or property and actions by the state and private persons to prosecute those acts; providing a civil penalty.

TX HB2062

Relating to false claims against the state and actions by the state and private persons to prosecute those claims; providing a civil penalty.

PA HB1437

Providing for liability for false claims, for adoption of congressional intent of the Federal False Claims Act, for damages, costs and civil penalties, for powers of Attorney General, for qui tam actions and for civil investigative demands.

PA SB38

Providing for liability for false claims, for adoption of congressional intent of the Federal False Claims Act, for damages, costs and civil penalties, for powers of Attorney General, for qui tam actions and for civil investigative demands.

VA HB1650

Virginia Antiterrorism Act established; civil penalties.

PA HB1371

Establishing cause of action for antitrust conduct, for indirect purchaser recovery under State antitrust laws and for premerger notice of health care mergers and transactions; and imposing penalties.

DE SB296

An Act To Amend Title 6 Of The Delaware Code Relating To Antitrust.

PA HB2012

Providing for cause of action for antitrust conduct, for indirect purchaser recovery under State antitrust laws and for premerger notice of health care mergers and transactions; and imposing penalties.